Optimisation of the foot-and-mouth disease virus 2A co-expression system for biomedical applications

BMC Biotechnology

Volumn 13, Issue , 2013, Pages

  Minskaia, Ekaterina ^a   Nicholson, John ^a   Ryan, Martin D ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Bicistronic vector; Co translational 'self cleavage'; Protein co expression

Indexed keywords

BICISTRONIC VECTOR; BIOMEDICAL APPLICATIONS; CLEAVAGE EFFICIENCY; CO-EXPRESSION; CO-EXPRESSION SYSTEMS; FOOT-AND-MOUTH DISEASE VIRUS; RETICULOCYTE LYSATES; SELF-CLEAVAGE;

MEDICAL APPLICATIONS; OPTIMIZATION; VIRUSES;

PROTEINS;

VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; FOOT AND MOUTH DISEASE VIRUS; FOOT AND MOUTH DISEASE VIRUS 2A; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; RETICULOCYTE LYSATE; VIRUS TRANSCRIPTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; PLASMIDS; TRANSGENES; VIRAL PROTEINS;

EID: 84882998955     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-13-67     Document Type: Article

References (39)

1. de Felipe P. Polycistronic viral vectors. Curr Gene Ther 2002, 2:355-378. 10.2174/1566523023347742, 12189721.
2. Pfutzner W. Retroviral bicistronic vectors. Drug News Perspectives 2008, 31:473-480.
3. Luke G. Translating 2A research into practice. Innovations in Biotechnology 2012, 161-186. Rijeka, Croatia: InTech, Agbo E.
4. Martinez-Salas E. Internal ribosome entry site biology and its use in expression vectors. Curr Opin Biotechnol 1999, 10:458-464. 10.1016/S0958-1669(99)00010-5, 10508627.
5. Wong ET, Ngoi SM, Lee CGL. Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes. Gene Ther 2002, 9:337-344. 10.1038/sj.gt.3301667, 11938453.
6. Kozak M. A second look at cellular mRNA sequences said to function as internal ribosome entry sites. Nucleic Acids Res 2005, 33:6593-6602. 10.1093/nar/gki958, 1298923, 16314320.
7. Baranick BT, Lemp NA, Nagashima J, Hiraoka K, Kasahara N, Logg CR. Splicing mediates the activity of four putative cellular internal ribosome entry sites. Proc Natl Acad Sci USA 2008, 105:4733-4738. 10.1073/pnas.0710650105, 2290820, 18326627.
8. Ryan MD, Donnelly MLL, Lewis A, Mehrotra AP, Wilkie J, Gani D. A model for non-stoichiometric, co-translational protein scission in eukaryotic ribosomes. Bioorganic Chem 1999, 27:55-79.
9. Atkins JF, Wills NM, Loughran G, Wu CY, Parsawar K, Ryan MD, Wang CH, Nelson CC. A case for 'StopGo': reprogramming translation to augment codon meaning of GGN by promoting unconventional termination (Stop) after addition of glycine and then allowing continued translation (Go). RNA 2007, 13:1-8. 1705751, 17123956.
10. Ryan MD, King AM, Thomas GP. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J Gen Virol 1991, 72:2727-2732. 10.1099/0022-1317-72-11-2727, 1658199.
11. Donnelly MLL, Hughes LE, Luke GA, Mendoza H, ten Dam E, Gani D, Ryan MD. The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol 2001, 82:1027-1041.
12. Klump H, Schiedlmeier B, Vogt B, Ryan M, Ostertag W, Baum C. Retroviral vector-mediated expression in HoxB4 in hematopoietic cells using a novel expression strategy. Gene Ther 2001, 8:811-817. 10.1038/sj.gt.3301447, 11420646.
13. Luke GA, de Felipe P, Lukashev A, Kallioinen SE, Bruno EA, Ryan MD. The occurrence, function, and evolutionary origins of '2A-like' sequences in virus genomes. J Gen Virol 2008, 89:1036-1042. 10.1099/vir.0.83428-0, 2885027, 18343847.
14. Ryan MD, Drew J. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J 1994, 13:928-933. 394894, 8112307.
15. de Felipe P, Hughes LE, Ryan MD, Brown JD. Co-translational, intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A peptide. J Biol Chem 2003, 278:11441-11448. 10.1074/jbc.M211644200, 12522142.
16. Ryan MD, Donnelly MLL, Flint M, Cowton VM, Luke GA, Hughes LE, Knox C, de Felipe P. Foot-and-mouth disease virus proteinases. Foot and Mouth Disease Current Perspectives 2004, 53-76. England: Horizon Bioscience, Sobrino F, Domingo E.
17. de Felipe P, Martin V, Cortes ML, Ryan M, Izquierdo M. Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy. Gene Ther 1998, 6:198-208.
18. Furler S, Paterna JC, Weibel M, Bueler H. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons. Gene Ther 2001, 8:864-873. 10.1038/sj.gt.3301469, 11423934.
19. Fang J, Qian J, Yi S, Harding TC, Tu G, VanRoey M, Jooss K. Stable antibody expression at therapeutic levels using the 2A peptide. Nat Biotechnol 2005, 23:584-590. 10.1038/nbt1087, 15834403.
20. Funston GM, Kallioinen SE, de Felipe P, Ryan MD. Expression of heterologous genes in oncolytic adenoviruses using picornaviral 2A sequences that trigger ribosome skipping. J Gen Virol 2008, 89:389-396. 10.1099/vir.0.83444-0, 18198369.
21. Trichas G, Begbie J, Srinivas S. Use of the viral 2A peptide for bicistronic expression in transgenic mice. BMC Biol 2008, 6:40. 10.1186/1741-7007-6-40, 2553761, 18793381.
22. Yang S, Cohen CJ, Peng PD, Zhao Y, Cassard L, Yu Z, Zheng Z, Jones S, Restifo NP, Rosenberg SA, Morgan RA. Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Ther 2008, 15:1411-1423. 10.1038/gt.2008.90, 2684456, 18496571.
23. Tan Y, Liang H, Chen A, Guo X. Co-expression of double or triple copies of the rabies virus glycoprotein gene using a 'self-cleaving' 2A peptide-based replication-defective human adenovirus serotype 5 vector. Biologicals 2010, 38:586-593. 10.1016/j.biologicals.2010.06.001, 20682459.
24. Takata Y, Kishine H, Sone T, Andoh T, Nozaki M, Poderycki M, Chesnut J, Imamoto F. Generation of iPS cells using a BacMam expression system. Cell Struct Funct 2011, 36:209-222. 10.1247/csf.11008, 21979235.
25. Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, Vignali DA. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat biotechnol 2004, 22:589-594. 10.1038/nbt957, 15064769.
26. Camper N, Byrne T, Burden RE, Lowry J, Gray B, Johnston JA, Migaud ME, Olwill SA, Buick RJ, Scott CJ. Stable expression and purification of a functional processed Fab' fragment from a single nascent polypeptide in CHO cells expressing the mCAT-1 retroviral receptor. J Immunol Methods 2011, 372:30-41. 10.1016/j.jim.2011.06.029, 21782818.
27. de Felipe P, Ryan MD. Targeting of proteins derived from self-processing polyproteins containing multiple signal sequences. Traffic 2004, 5:616-626. 10.1111/j.1398-9219.2004.00205.x, 15260831.
28. de Felipe P, Luke GA, Brown JD, Ryan MD. Inhibition of 2A-mediated 'cleavage' of certain artificial polyproteins bearing N-terminal signal sequences. Biotechnol J 2010, 5:213-223. 10.1002/biot.200900134, 2978324, 19946875.
29. Provost E, Rhee J, Leach SD. Viral 2A peptides allow expression of multiple proteins from a single ORF in transgenic zebrafish embryos. Genesis 2007, 45:625-629. 10.1002/dvg.20338, 17941043.
30. Hart DP, Xue S-A, Thomas S, Cesco-Gaspere M, Tranter A, Willcox B, Lee SP, Steven N, Morris EC, Stauss HJ. Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells. Gene Ther 2008, 15:625-631. 10.1038/sj.gt.3303078, 18305579.
31. Unger C, Karner E, Treschow A, Stellan B, Felldin U, Concha H, Wendel M, Hovatta O, Aints A, Ahrlund-Richter L, Dilber M. Lentiviral-mediated HoxB4 expression in himan embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation. Stem Cells 2008, 26:2455-2466. 10.1634/stemcells.2007-0876, 18617691.
32. Karner E, Unger C, Cerny R, Ahrlund-Richter L, Ganss B, Dilber M, Wendel M. Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: a dose-dependent effect of osterix over-expression. J Cell Psysiol 2009, 218:323-333.
33. Sommer CA, Stadfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G. iPS cell generation using a single lentiviral stem cell cassette. Stem Cells 2008, 27:543-549.
34. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, Jaenisch R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci 2009, 106:157-162. 10.1073/pnas.0811426106, 2629226, 19109433.
35. Shao LS, Feng W, Sun Y, Bai H, Liu J, Currie C, Kim J, Gama R, Wang Z, Qian Z, Liaw L, Wu WS. Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 2009, 19:296-310. 10.1038/cr.2009.20, 2821711, 19238173.
36. Lengler J, Holzmuller H, Salmons B, Gunzburg WH, Renner M. FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein. Anal Biochem 2005, 343:116-124. 10.1016/j.ab.2005.05.004, 15955524.
37. Sharma P, Yan F, Doronina VA, Escuin-Ordinas H, Ryan MD, Brown J. 2A peptides provide distinct solutions to driving stop-carry on translational recoding. Nucleic Acids Res 2012, 40:3143-3151. 10.1093/nar/gkr1176, 3326317, 22140113.
38. Ma C, Mitra A. Expressing multiple genes in a single open reading frame with the 2A region of foot-and-mouth disease virus as a linker. Mol breed 2002, 9:191-199.
39. Minskaia E, Ryan M. Protein co-expression using FMDV 2A: effect of 'linker' residues. Biomed Res Int in press.